中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
甲基2,3,4-三-O-苄基-α-D-吡喃葡萄糖苷 | methyl 2,3,4-tri-O-benzyl-D-glucopyranoside | 53008-65-4 | C28H32O6 | 464.558 |
—— | methyl 6-aldehydo-2,3,4-tri-O-benzyl-α-D-glucopyranoside | 83051-88-1 | C28H30O6 | 462.543 |
甲基2,3,4-三-O-苄基-6-O-三苯甲基-ALPHA-D-吡喃葡萄糖苷 | methyl 2,3,4-tri-O-benzyl-6-O-trityl-α-D-glucopyranoside | 18685-19-3 | C47H46O6 | 706.879 |
甲基-6-O-三苯基甲基-alpha-D-吡喃葡萄糖苷 | methyl 6-O-trityl-α-D-glucopyranoside | 18311-26-7 | C26H28O6 | 436.505 |
1,6-Dideoxy-6,6-difluoronojirimycin (1) was prepared from an easily accessible and commercially available starting material, methyl 2,3,4-tri-O-benzyl-α-D-glucopyranoside. Key steps of this synthesis are a difluorination reaction using DAST and a reductive amination. The overall yield of the synthesis is 44%. Compound 1 has been tested for its activity as an inhibitor of various glucosidases and galactosidases.